BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8225492)

  • 1. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
    Cantoreggi S; Gupta RC; Lutz WK
    IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC
    IARC Sci Publ; 1993; (124):11-23. PubMed ID: 8225473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.
    Munnia A; Saletta F; Allione A; Piro S; Confortini M; Matullo G; Peluso M
    Mutagenesis; 2007 Nov; 22(6):381-5. PubMed ID: 17716983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
    Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
    IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods.
    Reddy MV
    J Chromatogr; 1993 May; 614(2):245-51. PubMed ID: 8314936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E; Avitts TA; Reddy MV; Miller RH; Everson RB; Randerath K
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4).
    Funk D; Sorg BL; Lindner SC; Schmeiser HH
    Environ Mol Mutagen; 2010 May; 51(4):338-43. PubMed ID: 20120015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G; Roh JH; Getek T
    J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung DNA adducts detected in human smokers are unrelated to typical polyaromatic carcinogens.
    Arif JM; Dresler C; Clapper ML; Gairola CG; Srinivasan C; Lubet RA; Gupta RC
    Chem Res Toxicol; 2006 Feb; 19(2):295-9. PubMed ID: 16485906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization by 32P-postlabelling of 8-methoxypsoralen adducts.
    Gillardeaux O; Perin-Rousel O; Perin F
    IARC Sci Publ; 1993; (124):133-9. PubMed ID: 8225476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.